+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030- Product Image
Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Type (Detection Of Latent Infection, Phage Assay, Nucleic Acid Testing), By End-use (Diagnostic Laboratories, Hospitals & Clinic), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • March 2025
  • Region: Global
  • Grand View Research
  • ID: 5893234
Description Jump to:
The global tuberculosis diagnostics market size is expected to reach USD 3.18 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.

These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavors directed toward containing the incidence of this infectious disease.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the end results of these initiatives. This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.

Tuberculosis Diagnostics Market Report Highlights

  • The latent infection detection segment (Skin Test & IGRA) led the market in 2024 with a 40.59% share, driven by the increasing prevalence of tuberculosis.
  • Drug Resistance (DST) is projected to achieve the fastest CAGR during the forecast period. DST evaluates the susceptibility of Mycobacterium tuberculosis to various antibiotics, identifying which drugs are effective for treatment.
  • In 2024, the diagnostic laboratories segment dominated the TB diagnostics market with the largest revenue share, driven by initiatives to enhance patient outcomes through accessible, retail-level diagnostic services.
  • The hospitals and clinics segment is poised for significant growth, driven by increasing TB testing rates in healthcare settings.
  • The tuberculosis diagnostics market in Asia Pacific dominated the market with revenue share of 37.18% in 2024 and is expected to witness the fastest growth over the forecast period.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Tuberculosis Diagnostics Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.2. Market restraint analysis
3.1.3. Market opportunities analysis
3.2. Tuberculosis Diagnostics Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
3.2.3. COVID-19 Impact Analysis
3.2.4. Case Studies
Chapter 4. Tuberculosis Diagnostics Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Tuberculosis Diagnostics Market by Type Outlook
4.4. Detection of Latent Infection (Skin Test & IGRA)
4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.5. Phage Assay
4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.6. Detection of Drug Resistance (DST)
4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.7. Nucleic Acid Testing
4.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.8. Radiographic Method
4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.9. Cytokine Detection Assay
4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 5. Tuberculosis Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Tuberculosis Diagnostics Market by End Use Outlook
5.4. Diagnostic Laboratories
5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.5. Hospitals & Clinics
5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
Chapter 6. Tuberculosis Diagnostics Market: Regional Estimates & Trend Analysis, By Product, By Type, By End Use
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share/position analysis, 2024
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Technology Type benchmarking
7.4.1.4. Strategic initiatives
7.4.2. QIAGEN
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Technology Type benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Thermo Fisher Scientific Inc.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Technology Type benchmarking
7.4.3.4. Strategic initiatives
7.4.4. BD
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Technology Type benchmarking
7.4.4.4. Strategic initiatives
7.4.5. F. Hoffmann-La Roche AG
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Technology Type benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Hologic, Inc.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Technology Type benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Cepheid
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Technology Type benchmarking
7.4.7.4. Strategic initiatives
7.4.8. DiaSorin S.p.A.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Technology Type benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Hain Lifescience GmbH
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Technology Type benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Oxford Immunotec
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Technology Type benchmarking
7.4.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 4 North America Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 5 U.S. Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 6 U.S. Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 7 Canada Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 8 Canada Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 9 Mexico Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 10 Mexico Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 11 Europe Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 12 Europe Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 13 UK Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 14 UK Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 15 Germany Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 16 Germany Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 17 France Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 18 France Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 19 Italy Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 20 Italy Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 21 Spain Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 22 Spain Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 23 Denmark Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 24 Denmark Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 25 Sweden Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 26 Sweden Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 27 Norway Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 28 Norway Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 31 Japan Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 32 Japan Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 33 China Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 34 China Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 35 India Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 36 India Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 37 Australia Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 38 Australia Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 39 South Korea Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 40 South Korea Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 41 Thailand Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 42 Thailand Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 43 Latin America Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 44 Latin America Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 45 Brazil Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 46 Brazil Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 47 Argentina Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 48 Argentina Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 49 MEA Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 50 MEA Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 51 South Africa Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 52 South Africa Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 55 UAE Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 56 UAE Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
Table 57 Kuwait Tuberculosis Diagnostics market estimates and forecasts by type, 2018 - 2030 (USD Million)
Table 58 Kuwait Tuberculosis Diagnostics market estimates and forecasts by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Tuberculosis Diagnostics market outlook
Fig. 9 Tuberculosis Diagnostics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Tuberculosis Diagnostics market driver impact
Fig. 15 Tuberculosis Diagnostics market restraint impact
Fig. 16 Tuberculosis Diagnostics market strategic initiatives analysis
Fig. 17 Tuberculosis Diagnostics market: Type analysis
Fig. 18 Tuberculosis Diagnostics market: Type outlook and key takeaways
Fig. 19 Detection of Latent Infection (Skin Test & IGRA) market estimates and forecast, 2018 - 2030
Fig. 20 Phage assay market estimates and forecast, 2018 - 2030
Fig. 21 Detection of Drug Resistance (DST) market estimates and forecast, 2018 - 2030
Fig. 22 Nucleic Acid Testing market estimates and forecast, 2018 - 2030
Fig. 23 Radiographic method market estimates and forecast, 2018 - 2030
Fig. 24 Cytokine detection assay market estimates and forecast, 2018 - 2030
Fig. 25 Others market estimates and forecast, 2018 - 2030
Fig. 26 Lumbar puncture market estimates and forecast, 2018 - 2030
Fig. 27 Nerve conduction studies market estimates and forecast, 2018 - 2030
Fig. 28 Electromyography market estimates and forecast, 2018 - 2030
Fig. 29 Others market estimates and forecast, 2018 - 2030
Fig. 30 Tuberculosis Diagnostics market: End use movement analysis
Fig. 31 Tuberculosis Diagnostics market: End use outlook and key takeaways
Fig. 32 Diagnostic laboratories market estimates and forecast, 2018 - 2030
Fig. 33 Hospitals & clinics market estimates and forecast, 2018 - 2030
Fig. 34 Others market estimates and forecast, 2018 - 2030
Fig. 35 Global Tuberculosis Diagnostics market: Regional movement analysis
Fig. 36 Global Tuberculosis Diagnostics market: Regional outlook and key takeaways
Fig. 37 Global Tuberculosis Diagnostics market share and leading players
Fig. 38 North America market share and leading players
Fig. 39 Europe market share and leading players
Fig. 40 Asia Pacific market share and leading players
Fig. 41 Latin America market share and leading players
Fig. 42 Middle East & Africa market share and leading players
Fig. 43 North America: SWOT
Fig. 44 Europe SWOT
Fig. 45 Asia Pacific SWOT
Fig. 46 Latin America SWOT
Fig. 47 MEA SWOT
Fig. 48 North America market estimates and forecasts, 2018 - 2030
Fig. 49 U.S. market estimates and forecasts, 2018 - 2030
Fig. 50 Canada market estimates and forecasts, 2018 - 2030
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
Fig. 52 Europe market estimates and forecasts, 2018 - 2030
Fig. 53 UK market estimates and forecasts, 2018 - 2030
Fig. 54 Germany market estimates and forecasts, 2018 - 2030
Fig. 55 France market estimates and forecasts, 2018 - 2030
Fig. 56 Italy market estimates and forecasts, 2018 - 2030
Fig. 57 Spain market estimates and forecasts, 2018 - 2030
Fig. 58 Denmark market estimates and forecasts, 2018 - 2030
Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
Fig. 60 Norway market estimates and forecasts, 2018 - 2030
Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 62 China market estimates and forecasts, 2018 - 2030
Fig. 63 Japan market estimates and forecasts, 2018 - 2030
Fig. 64 India market estimates and forecasts, 2018 - 2030
Fig. 65 Thailand market estimates and forecasts, 2018 - 2030
Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
Fig. 67 Australia market estimates and forecasts, 2018 - 2030
Fig. 68 Latin America market estimates and forecasts, 2018 - 2030
Fig. 69 Brazil market estimates and forecasts, 2018 - 2030
Fig. 70 Argentina market estimates and forecasts, 2018 - 2030
Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 72 South Africa market estimates and forecasts, 2018 - 2030
Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 74 UAE market estimates and forecasts, 2018 - 2030
Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 76 Market share of key market players- Tuberculosis Diagnostics market
Fig. 77 Key Company Categorization
Fig. 78 Company Market Share/Position Analysis, 2024
Fig. 79 Strategic Framework

Companies Mentioned

  • Abbott
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • BD
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Cepheid
  • DiaSorin S.p.A.
  • Hain Lifescience GmbH
  • Oxford Immunotec

Methodology

Loading
LOADING...

Related Topics

Related Reports

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test Type, Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report by Brand (QFT-Plus), Test Type, Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Tuberculosis Diagnostics Market by Test Type, Type, End_User - Global Forecast 2025-2030 - Product Image

Tuberculosis Diagnostics Market by Test Type, Type, End_User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Tuberculosis Testing Market by Test, Indication, Testing Location, End User - Global Forecast 2025-2030 - Product Image

Tuberculosis Testing Market by Test, Indication, Testing Location, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Tuberculosis Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Tuberculosis Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 156 Pages
  • Global
From
Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Tuberculosis Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.